Company Filing History:
1 out of 14 
1 out of 378 
1 out of 1 Years Active: 2011-2024
Title: Doris Hafenbradl: Innovator in Pharmaceutical and Biotechnological Patents
Introduction
Doris Hafenbradl is a prominent inventor based in Pullach, Germany. She has made significant contributions to the fields of pharmaceuticals and biotechnology, holding a total of 2 patents. Her work focuses on innovative methods and compounds that have the potential to impact various medical conditions.
Latest Patents
Hafenbradl's latest patents include a method for controlling the quality of Archaea cultures. This invention allows for the typing of Archaea and the quick discrimination of contaminants in pure strain cultures of methanogenic Archaea. This method leads to the isolation of variants with mutations from the culture population. Another notable patent involves pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives. These derivatives serve as modulators of protein kinases and are aimed at treating a wide range of diseases, including infectious, immunological, and neurodegenerative diseases. The invention also covers pharmaceutical compositions containing these derivatives and their use as inhibitors for protein kinases.
Career Highlights
Throughout her career, Doris Hafenbradl has worked with notable companies such as Lead Discovery Center GmbH and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in drug discovery and development.
Collaborations
Doris has collaborated with esteemed colleagues, including Axel Choidas and Alexander Backes. These partnerships have further enhanced her research and innovation capabilities.
Conclusion
Doris Hafenbradl is a remarkable inventor whose work in pharmaceuticals and biotechnology continues to pave the way for advancements in medical treatments. Her patents reflect her dedication to improving health outcomes through innovative solutions.